Latest filing published 24 Jun 2026 for Pediatrix Medical Group, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
David Haddock, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Magellan Health Inc and Pediatrix Medical Group, Inc. Over a trading history stretching from 4 January 2022 to 22 June 2026, the count stands at 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 24 June 2026: a share grant, in Pediatrix Medical Group, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations